Overall rank by patents
#9,097
Across all tracked assignees
USPTO PatentsView assignee record - 35 granted patents across 50 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B25J (MANIPULATORS; CHAMBERS PROVIDED WITH MANIPULATION DEVICES).
The verdict
Other holds 35 US patents across 50 technology areas, rank #9,097 of 50,000 tracked assignees.
Other LAB, Llc has been granted 35 US utility patents between 2015 and 2025, placing Other LAB, Llc at rank #9,097 across all assignees tracked by PlainPatent. This portfolio spans 50 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.4 claims per patent with primary concentration in B25J (MANIPULATORS; CHAMBERS PROVIDED WITH MANIPULATION DEVICES). As a US Corporation, Other LAB, Llc is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Other sits between Nihon University (35 patents, rank #9,093) and PARI Pharma Gmbh (35 patents, rank #9,101) - the closest US assignees by grant volume. The composite Innovation Score of 52.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 28 grants, compared with 7 in the 2015–2019 window, a +300% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Other LAB, Llc's 18.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 50 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Other LAB, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NIHON UNIVERSITY
35 patents
NeuroNexus Technologies, Inc.
35 patents
OIL STATES ENERGY SERVICES, L.L.C.
35 patents
OSSTEM IMPLANT CO., LTD
35 patents
Occlutech GmbH
35 patents
P&W SOLUTIONS CO., LTD.
35 patents
PANASONIC SEMICONDUCTOR SOLUTIONS CO., LTD.
35 patents
PARI Pharma GmbH
35 patents
OTHER LAB, LLC
35 patents
What this shows Other holds 35 patents at rank #9,097, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #9,097 in granted patent volume.
Other assignees with the most granted patents in Other's primary technology class.
Other's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 2.9% |
| 2017 | 2 | 5.7% |
| 2018 | 4 | 11.4% |
| 2020 | 13 | 37.1% |
| 2021 | 4 | 11.4% |
| 2022 | 2 | 5.7% |
| 2023 | 3 | 8.6% |
| 2024 | 4 | 11.4% |
| 2025 | 2 | 5.7% |
Top 15 of 50 technology areas
Overall rank by patents
#9,097
Across all tracked assignees
52.0 out of 100
How to use this portfolio
Other's 35 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.